Considering the FAERS data from the past 20 years in neonates and infants, the use of PPI monotherapy exhibited an increasing trend until 2016, followed by a declining trend from 2016 to the present.
← all excerpts
Real-World Safety Profile of Proton Pump Inhibitors in Infants as Reported in the FDA Adverse Event Reporting System (FAERS): Tiny Tummies, Key Decisions.
1
—
—